DSpace Repository

Efficacy and safety of erdafitinib in pediatric patients with advanced solid tumors and FGFR alterations in the phase 2 RAGNAR trial

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account

Statistics